We're Not Worried About LTR Pharma's (ASX:LTP) Cash Burn
Oct 18
Have your own idea? Try our Stock Screener
Australian (ASX) Pharma Industry Analysis
UpdatedJan 12, 2026
DataAggregated Company Financials
Companies26
- 7D1.2%
- 3M-11.7%
- 1Y5.3%
- YTD1.2%
Over the last 7 days, the Pharma industry has risen 1.2%, driven by gains in Neuren Pharmaceuticals and Clarity Pharmaceuticals of 1.6% and 2.4%, respectively. During this same period, the LTR Pharma underperformed, falling 11%. This means that the industry has gained 5.3% over the past year. As for the next few years, earnings are expected to grow by 34% per annum.
Industry Valuation and Performance
Has the Australian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 12 Jan 2026 | AU$5.8b | AU$1.0b | -AU$199,680,775.00 | 15.7x | -29.1x | 5.8x |
| Wed, 10 Dec 2025 | AU$5.4b | AU$1.0b | -AU$199,680,775.00 | 14.2x | -27.3x | 5.4x |
| Fri, 07 Nov 2025 | AU$5.9b | AU$1.0b | -AU$202,211,775.00 | 14.1x | -29x | 5.9x |
| Sun, 05 Oct 2025 | AU$6.6b | AU$1.0b | -AU$202,211,775.00 | 14.6x | -32.8x | 6.6x |
| Tue, 02 Sep 2025 | AU$5.3b | AU$1.0b | -AU$220,056,070.00 | 14.1x | -23.9x | 5.3x |
| Thu, 31 Jul 2025 | AU$5.5b | AU$1.0b | -AU$210,394,927.00 | 14.8x | -26.3x | 5.4x |
| Sat, 28 Jun 2025 | AU$4.6b | AU$1.1b | -AU$225,511,927.00 | 14.9x | -20.3x | 4.4x |
| Mon, 26 May 2025 | AU$4.4b | AU$1.0b | -AU$238,266,485.00 | 17.6x | -18.5x | 4.2x |
| Wed, 23 Apr 2025 | AU$4.1b | AU$1.0b | -AU$238,266,485.00 | 16.9x | -17.2x | 3.9x |
| Fri, 21 Mar 2025 | AU$5.0b | AU$1.1b | -AU$289,508,485.00 | 18.9x | -17.2x | 4.7x |
| Sun, 16 Feb 2025 | AU$5.3b | AU$1.0b | -AU$377,002,613.00 | 14.2x | -14.1x | 5.2x |
| Tue, 14 Jan 2025 | AU$5.1b | AU$1.0b | -AU$378,981,112.00 | 12.2x | -13.6x | 5.1x |
| Thu, 12 Dec 2024 | AU$5.7b | AU$1.0b | -AU$378,981,112.00 | 13.1x | -15.1x | 5.6x |
| Sat, 09 Nov 2024 | AU$6.8b | AU$1.0b | -AU$377,703,112.00 | 14.2x | -18x | 6.7x |
| Mon, 07 Oct 2024 | AU$6.6b | AU$1.0b | -AU$377,703,112.00 | 12.9x | -17.5x | 6.5x |
| Wed, 04 Sep 2024 | AU$6.5b | AU$1.0b | -AU$383,620,117.00 | 13.4x | -16.8x | 6.3x |
| Fri, 02 Aug 2024 | AU$6.7b | AU$995.3m | -AU$387,920,108.00 | 11.1x | -17.3x | 6.7x |
| Sun, 30 Jun 2024 | AU$6.6b | AU$995.3m | -AU$387,920,108.00 | 11.5x | -16.9x | 6.6x |
| Tue, 28 May 2024 | AU$6.7b | AU$1.2b | -AU$374,923,684.00 | 14.7x | -17.8x | 5.5x |
| Thu, 25 Apr 2024 | AU$5.5b | AU$1.2b | -AU$374,923,684.00 | 13.2x | -14.6x | 4.5x |
| Sat, 23 Mar 2024 | AU$5.6b | AU$1.2b | -AU$374,923,684.00 | 15.3x | -15x | 4.6x |
| Mon, 19 Feb 2024 | AU$5.3b | AU$892.3m | -AU$534,729,129.00 | 20.4x | -9.9x | 5.9x |
| Wed, 17 Jan 2024 | AU$5.7b | AU$896.3m | -AU$589,604,392.00 | 21.2x | -9.6x | 6.3x |
| Fri, 15 Dec 2023 | AU$4.5b | AU$896.3m | -AU$589,604,392.00 | 17.1x | -7.7x | 5.1x |
| Sun, 12 Nov 2023 | AU$4.0b | AU$893.0m | -AU$595,020,018.00 | 18.1x | -6.7x | 4.5x |
| Tue, 10 Oct 2023 | AU$3.5b | AU$900.3m | -AU$587,952,018.00 | 19x | -6x | 3.9x |
| Thu, 07 Sep 2023 | AU$3.7b | AU$900.3m | -AU$587,952,018.00 | 19.5x | -6.3x | 4.1x |
| Sat, 05 Aug 2023 | AU$4.1b | AU$999.0m | -AU$624,794,303.00 | 21.1x | -6.5x | 4.1x |
| Mon, 03 Jul 2023 | AU$4.0b | AU$999.0m | -AU$624,794,303.00 | 22.7x | -6.3x | 4x |
| Wed, 31 May 2023 | AU$4.0b | AU$993.2m | -AU$640,306,659.00 | 18.9x | -6.3x | 4.1x |
| Fri, 28 Apr 2023 | AU$4.2b | AU$993.2m | -AU$641,969,868.00 | 19x | -6.6x | 4.3x |
| Sun, 26 Mar 2023 | AU$4.0b | AU$995.9m | -AU$648,651,745.00 | 18.2x | -6.2x | 4.1x |
| Tue, 21 Feb 2023 | AU$3.6b | AU$980.5m | -AU$583,404,566.00 | 16.5x | -6.1x | 3.6x |
| Thu, 19 Jan 2023 | AU$4.1b | AU$948.3m | -AU$544,428,006.00 | 12.9x | -7.6x | 4.3x |
Price to Earnings Ratio
-7.6x
Current Industry PE
- Investors are optimistic on the Australian Pharmaceuticals industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 5.0x is lower than the industry's current PS ratio of 5.8x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
- Meanwhile revenues have remained mostly flat.
- This means that companies overall are more efficiently conducting business since losses are shrinking while sales have been flat.
Industry Trends
Which industries have driven the changes within the Australian Healthcare industry?
| AU Market | 0.16% | |
| Healthcare | -0.13% | |
| Pharma | 1.21% | |
| Pharma | 1.21% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| NEU Neuren Pharmaceuticals | AU$19.32 | 1.6% +AU$38.0m | 63.0% | PE16.4x | |
| VLS Vita Life Sciences | AU$2.79 | 7.3% +AU$10.4m | 43.8% | PE16.4x | |
| BOT Botanix Pharmaceuticals | AU$0.14 | 3.7% +AU$9.8m | -71.4% | PS47.6x | |
| ALA Arovella Therapeutics | AU$0.094 | 4.4% +AU$4.8m | -50.5% | PS32.8x | |
| CU6 Clarity Pharmaceuticals | AU$3.85 | 0.3% +AU$3.7m | 2.4% | PS151.4x |